Stocks and Investing Stocks and Investing
Mon, October 9, 2017
Fri, October 6, 2017

Matthew Harrison Maintained (AMGN) at Buy with Increased Target to $196 on, Oct 6th, 2017


Published on 2024-10-25 23:16:34 - WOPRAI, Matthew Harrison
  Print publication without navigation


Matthew Harrison of Morgan Stanley, Maintained "Amgen Inc." (AMGN) at Buy with Increased Target from $189 to $196 on, Oct 6th, 2017.

Matthew has made no other calls on AMGN in the last 4 months.



There are 6 other peers that have a rating on AMGN. Out of the 6 peers that are also analyzing AMGN, 4 agree with Matthew's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Michael Yee of "RBC Capital" Initiated at Hold and Held Target at $192 on, Friday, September 15th, 2017
  • Ian Somaiya of "BMO Capital" Downgraded from Buy to Hold on, Wednesday, July 26th, 2017
  • Carter Gould of "UBS" Maintained at Hold with Increased Target to $185 on, Wednesday, July 26th, 2017
  • Andrew Peters of "Deutsche Bank" Initiated at Hold and Held Target at $172 on, Friday, June 23rd, 2017


These are the ratings of the 2 analyists that currently disagree with Matthew


  • Alethia Young of "Credit Suisse" Maintained at Buy with Increased Target to $186 on, Friday, September 29th, 2017
  • David Toung of "Argus Research" Maintained at Strong Buy with Increased Target to $195 on, Thursday, July 27th, 2017
Contributing Sources